Myogenix admits selling synthetic steroids in corporate plea

[Millard]

Myogenix enters corporate plea agreement related to sale of synthetic steroid "Spawn" sold as a dietary supplement between 2007 and 2009. Another fair resolution reached with counsel of our friend Rick Collins.

Myogenix director of operations Mark Newman entered a guilty plea on behalf of the company to charges related to "introducing unapproved drugs into interstate commerce with the intent to defraud and mislead," according to the DOJ.

Myogenix was fined $50,000 and had to forfeit $100,000 that was deemed to have been gained illegally.

As part of plea agreements, for the next five years the company must submit all products to an independent testing organization, the results of which must be reviewed by the FDA before the product can be sold.

San Jose: Supplement company admits in federal court to mislabeling synthetic steroids - San Jose Mercury News